BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies
US biotech BioMarin has partnered Swiss startup DiNAQOR to develop gene therapies to treat rare,…
07/05/2020 - 2 minutes
News and Trends
Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal
The French biotech Valneva will collaborate with Pfizer to develop and commercialize Valneva’s phase II-stage…
07/05/2020 - 4 minutes
Update: Kurma Partners’ Third Biofund Closes at €160M
Update (30/04/2020): The French VC firm Kurma Partners has completed the final closing of its…
30/04/2020 - 2 minutes
Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans
Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner…
29/04/2020 - 5 minutes
Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy
Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from…
29/04/2020 - 3 minutes
AskBio Takes Over French Gene Therapy Company to Treat Alzheimer’s and Huntington’s
The Paris-based BrainVectis, a biotech developing gene therapies for Huntington’s disease and Alzheimer’s disease, has…
28/04/2020 - 3 minutes
Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition
Japanese pharma giant Astellas has acquired the UK biotech Nanna Therapeutics for up to €80M…
28/04/2020 - 3 minutes
Series A Round Boosts Swedish Synthetic Biology Player by €6.4M
The Swedish synthetic biology company EnginZyme has raised a Series A funding round to the…
27/04/2020 - 4 minutes
Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland
The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop…
24/04/2020 - 3 minutes
First Volunteers Dosed with European Coronavirus Vaccine
The first European vaccine for coronavirus disease to enter clinical trials has been administered to…
24/04/2020 - 3 minutes
UK Startup to Manufacture Cell and Gene Therapies with Microfluidics
The UK company MicrofluidX has closed a €1.6M (£1.4 M) seed funding round to develop…
24/04/2020 - 3 minutes
Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies
The UK cell conversion startup Mogrify and the US genomic medicine company Sangamo have reached…
23/04/2020 - 3 minutes
